S'identifier

Laura Heiser

Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute

Oregon Health and Science University

BIOGRAPHY

Laura Heiser has not added Biography.

If you are Laura Heiser and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.

Molecular cancer therapeutics Dec, 2017 | Pubmed ID: 28958991

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.

Scientific reports Mar, 2019 | Pubmed ID: 30846826

BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.

Oncogene Apr, 2019 | Pubmed ID: 30996246

INSTITUTIONS

Oregon Health and Science University

JOVE ARTICLES

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Rebecca Smith¹,

Kaylyn Devlin¹,

David Kilburn¹,

Sean Gross¹,

Damir Sudar²,

Elmar Bucher¹,

Michel Nederlof²,

Mark Dane¹,

Joe W. Gray¹,

Laura Heiser¹,

James E. Korkola¹

¹Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health and Science University,

², Quantitative Imaging Systems LLC

Cancer Research

Confidentialité

Conditions d'utilisation

Politiques

Contactez-nous

RECOMMANDER À LA BIBLIOTHÈQUE

NEWSLETTERS JoVE

Recherche

JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives

Enseignement

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Faculty Site

Auteurs

Vue d'ensemble
Processus de publication
Comité éditorial
Domaines et politique de publication
Révision par les pairs
FAQ
Soumettre

Bibliothécaires

Vue d'ensemble
Témoignages
Abonnements
Accès
Ressources
Conseil consultatif des bibliothèques
FAQ

À PROPOS DE JoVE

Vue d'ensemble
Direction
Blog

Laura Heiser

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Biomedical Engineering,Knight Cancer Institute,Department of Biomedical Engineering, Knight Cancer Institute

Oregon Health and Science University

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute